30.26USD+3.81%Mkt Cap: 1.48B $P/E: —1d ago
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap1.48B $
Enterprise Value1.36B $
Revenue (TTM)101.66M $
Gross Profit62.12M $
Net Income (TTM)-4.59M $
Revenue/Share2.114 USD
Last Price30.26 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees155
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)91.70
PEG15.09
EV/EBITDA314.29
EV/Revenue13.36
P/S14.54
P/B3.97
EPS (TTM)-0.24
EPS (Forward)0.33
52W Range
17.86100% of range30.31
52W High30.31 USD
52W Low17.86 USD
Profitability
Gross Margin64.56%
Oper. Margin0.10%
EBITDA Margin4.25%
Profit Margin-4.78%
ROE-1.24%
ROA-1.13%
Growth
Revenue Growth24.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF20.11M $
CapEx (TTM)19.70M $
FCF Margin6.29%
FCF Yield0.43%
Net Debt-66.14M $
Net Debt/EBITDA-15.31
Balance Sheet
Debt/Equity0.05
Current Ratio7.30
Quick Ratio5.15
Book Value/Sh7.624 USD
Cash/Share1.658 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJan 29, 2014
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)32.11 USD
Upside (mean)+6.1%
Target Range30.00 USD – 34.00 USD
$30.00+6.1% to mean$34.00
# Analysts9
Ownership
Shares Out.48.86M
Float42.68M
Insiders2.37%
Institutions104.50%
Short Interest
Short Ratio2.7d
Short % Float9.66%
Short % Out.6.17%
Shares Short3.01M
Short (prev mo.)3.98M
Technical
SMA 5025.50 (+18.7%)
SMA 20024.14 (+25.3%)
Beta1.94
S&P 52W Chg20.25%
Avg Vol (30d)905.65K
Avg Vol (10d)582.57K
Technical Indicators
RSI (14)70.9
MACD1.0192
MACD Signal0.9281
MACD Hist.+0.0911
BB Upper30.52 USD
BB Middle27.54 USD
BB Lower24.56 USD
BB Width21.62%
ATR (14)1.213 USD
Vol Ratio (20d)0.84x